Carmentix Pte Ltd.

About:

Carmentix is a venture backed company developing a novel biomarker prognostic panel for pre term birth.

Top Investors: Esco Ventures

Description:

Carmentix enables early prevention of preterm birth through prediction. It develops a novel biomarker prognostic panel for preterm birth. They reduce the number of preterm birth in the global setting by establishing biomolecular tools that will alert clinicians for the risk of preterm birth weeks before symptoms occur.

Total Funding Amount:

$3.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Singapore, Central Region, Singapore

Founded Date:

2015-01-01

Founders:

Nir Arbel

Number of Employees:

1-10

Last Funding Date:

2015-06-24

IPO Status:

Private

Industries: